Company / Current Assets per Share
Trevi Therapeutics, Inc. Current Assets per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.07
FY2024
5-year range
$0.88 / $2.56
FY2020-FY2024
Trend
+21.4%
vs FY2023
Sector context
#191 of 210
Health Care
What the data says
Among 210 Health Care companies, Trevi Therapeutics, Inc. is in the bottom 9% for current assets per share. Current Assets per Share has fluctuated over the past 7 years, ranging from $0.88 in FY2023 to $20.16 in FY2018.
Based on SEC 10-K filings.
1.07 in FY2024 with a 5-year CAGR of -26.7%.
Declined from $1.90 to $1.07 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.6%
- 5-Year CAGR
- -26.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 210This company $1.07 Sector average $170.65
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 21.4% year-over-year.
- Ranks #191 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.07 | +21.4% |
| FY2023 | $0.88 | -53.5% |
| FY2022 | $1.90 | +14.3% |
| FY2021 | $1.66 | -35.1% |
| FY2020 | $2.56 | -49.5% |
| FY2019 | $5.07 | -74.8% |
| FY2018 | $20.16 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026